ECL1i
ECL1i is an allosteric, selective CCR2 inhibitor. ECL1i specifically inhibits CCL2-/CCR2-mediated chemotaxis. ECL1i interferes with CCR2-positive cell recruitment and attenuates disease progression in experimental autoimmune encephalomyelitis.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1417312-35-6
- Formule: C36H60N8O9S
- Masse moléculaire:780.97
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
|
CCR2 |
Chemical Information
-
CAS No. 1417312-35-6
-
Masse moléculaire 780.97
-
Formule C36H60N8O9S
-
Sequence
d(Leu-Gly-Thr-Phe-Leu-Lys-Cys)
-
Sequence Shortening
d(LGTFLKC)
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)